Upregulation of TRAG3 gene in urothelial carcinoma of the bladder

International Journal of Cancer

Volumn 128, Issue 12, 2011, Pages 2823-2832

  Karam, Jose A ^a,f   Huang, Sandra ^a   Fan, Jinhai ^a,b   Stanfield, Jennifer ^a   Schultz, Roger A ^c   Pong, Rey Chen ^a   Sun, Xiankai ^c   Mason, Ralph P ^c   Xie, Xian Jin ^c   Niu, Gang ^d   Chen, Xiaoyuan ^d   Frenkel, Eugene P ^c   Sagalowsky, Arthur I ^a   Hsieh, Jer Tsong ^a,e  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d STANFORD UNIVERSITY   (United States)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f UNIVERSITY OF TEXAS   (United States)

Author keywords

bladder; resistance; TRAG3; urothelial carcinoma

Indexed keywords

DOCETAXEL; DOXORUBICIN; MITOMYCIN; ONCOPROTEIN; TAXOL RESISTANCE ASSOCIATED PROTEIN 3; UNCLASSIFIED DRUG; VINBLASTINE;

ARTICLE; BLADDER CARCINOMA; CHROMOSOME ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOGENETICS; DNA METHYLATION; DNA MICROARRAY; DRUG EFFICACY; EPIGENETICS; GENE EXPRESSION; GENE FUNCTION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; TRAG3 GENE; TUMOR GROWTH; UPREGULATION; UROTHELIAL CARCINOMA OF THE BLADDER;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BASE SEQUENCE; CARCINOMA, TRANSITIONAL CELL; DNA PRIMERS; FEMALE; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 79955415203     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25631     Document Type: Article

References (19)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ,. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96. (Pubitemid 351521864)
2. Garcia JA, Dreicer R,. Systemic chemotherapy for advanced bladder cancer: update and controversies. J Clin Oncol 2006; 24: 5545-51. (Pubitemid 46631335)
3. Duan Z, Feller AJ, Toh HC, Makastorsis T, Seiden MV,. TRAG-3, a novel gene, isolated from a taxol-resistant ovarian carcinoma cell line. Gene 1999; 229: 75-81. (Pubitemid 29148309)
4. Karam JA, Fan J, Stanfield J, Richer E, Benaim EA, Frenkel E, Antich P, Sagalowsky AI, Mason RP, Hsieh JT,. The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy. Int J Cancer 2007; 120: 1795-802. (Pubitemid 46399368)
5. Chen H, Toyooka S, Gazdar AF, Hsieh JT,. Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines. J Biol Chem 2003; 278: 3121-30. (Pubitemid 36801222)
6. Yao X, Hu JF, Li T, Yang Y, Sun Z, Ulaner GA, Vu TH, Hoffman AR,. Epigenetic regulation of the taxol resistance-associated gene TRAG-3 in human tumors. Cancer Genet Cytogenet 2004; 151: 1-13. (Pubitemid 38569630)
7. Zhu B, Chen Z, Cheng X, Wu Y,. Induction of TRAG-3 expression in A549 lung adenocarcinoma cell line by 5-aza-2â deoxyazacytidine. Lung Cancer 2002; 38: 321-2. (Pubitemid 35341809)
8. Hoglund M, Gisselsson D, Hansen GB, White VA, Sall T, Mitelman F, Horsman D,. Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution. Int J Cancer 2004; 108: 57-65. (Pubitemid 37444444)
9. Hoglund M, Gisselsson D, Sall T, Mitelman F,. Coping with complexity. multivariate analysis of tumor karyotypes. Cancer Genet Cytogenet 2002; 135: 103-9. (Pubitemid 34786761)
10. Wu KL, Beverloo B, Velthuizen SJ, Sonneveld P,. Sequential analysis of chromosome aberrations in multiple myeloma during disease progression. Clin Lymphoma Myeloma 2007; 7: 280-5. (Pubitemid 46408192)
11. Sternberg CN, Yagoda A, Scher HI, Watson RC, Ahmed T, Weiselberg LR, Geller N, Hollander PS, Herr HW, Sogani PC, et al. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 1985; 133: 403-7. (Pubitemid 15129797)
12. Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N, et al. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 1989; 64: 2448-58. (Pubitemid 20014925)
13. von der Maase H, Sengelov L, Roberts JT, Ricci S, Dogliotti L, Oliver T, Moore MJ, Zimmermann A, Arning M,. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 2005; 23: 4602-8. (Pubitemid 46224062)
14. Gildea JJ, Seraj MJ, Oxford G, Harding MA, Hampton GM, Moskaluk CA, Frierson HF, Conaway MR, Theodorescu D,. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 2002; 62: 6418-23. (Pubitemid 35364098)
15. Feller AJ, Duan Z, Penson R, Toh HC, Seiden MV,. TRAG-3, a novel cancer/testis antigen, is overexpressed in the majority of melanoma cell lines and malignant melanoma. Anticancer Res 2000; 20: 4147-51. (Pubitemid 32141756)
16. Ohta M, Tanaka F, Sadanaga N, Yamaguchi H, Inoue H, Mori M,. Expression of the TRAG-3 gene in human esophageal cancer: the frequent synchronous expression of MAGE-3 gene. Oncol Rep 2006; 15: 1529-32.
17. Narayan G, Bourdon V, Chaganti S, Arias-Pulido H, Nandula SV, Rao PH, Gissmann L, Durst M, Schneider A, Pothuri B, Mansukhani M, Basso K, et al. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer 2007; 46: 373-84. (Pubitemid 46411328)
18. Lin C, Mak S, Meitner PA, Wolf JM, Bluman EM, Block JA, Terek RM,. Cancer/testis antigen CSAGE is concurrently expressed with MAGE in chondrosarcoma. Gene 2002; 285: 269-78. (Pubitemid 34246343)
19. Materna V, Surowiak P, Kaplenko I, Spaczynski M, Duan Z, Zabel M, Dietel M, Lage H,. Taxol-resistance-associated gene-3 (TRAG-3/CSAG2) expression is predictive for clinical outcome in ovarian carcinoma patients. Virchows Arch 2007; 450: 187-94. (Pubitemid 46295232)